Akero Therapeutics
AKRO
$19.66
Share price
-0.25%
Change (1 day)
-55.25%
Change (1 year)
Categories
Akero Therapeutics (AKRO) Fails to deliver data
Key failure to deliver metrics for Akero Therapeutics:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.31 M
- Last 3 months FTD volume: $2.04 M
- Last year FTD volume: $15.58 M
Failures to deliver for Akero Therapeutics (AKRO) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Akero Therapeutics (AKRO) - since 2019
Volume in USD (price x number of shares), data since 2019Akero Therapeutics (AKRO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $2.07 M | -85.71% |
| 2023 | $14.49 M | -3.77% |
| 2022 | $15.06 M | 105.18% |
| 2021 | $7.34 M | -52.08% |
| 2020 | $15.32 M | 114.88% |
| 2019 | $7.12 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.25 M | $6.85 M | 🇺🇸 USA |